JP2023503455A5 - - Google Patents
Info
- Publication number
- JP2023503455A5 JP2023503455A5 JP2022529681A JP2022529681A JP2023503455A5 JP 2023503455 A5 JP2023503455 A5 JP 2023503455A5 JP 2022529681 A JP2022529681 A JP 2022529681A JP 2022529681 A JP2022529681 A JP 2022529681A JP 2023503455 A5 JP2023503455 A5 JP 2023503455A5
- Authority
- JP
- Japan
- Prior art keywords
- capsid protein
- modified
- seq
- targeting peptide
- different brain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025044678A JP7888221B2 (ja) | 2019-11-22 | 2025-03-19 | アデノ随伴ウイルスベクター変種 |
| JP2025116303A JP2025148448A (ja) | 2019-11-22 | 2025-07-10 | アデノ随伴ウイルスベクター変種 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962939315P | 2019-11-22 | 2019-11-22 | |
| US62/939,315 | 2019-11-22 | ||
| US202063084709P | 2020-09-29 | 2020-09-29 | |
| US63/084,709 | 2020-09-29 | ||
| PCT/US2020/061464 WO2021102234A1 (en) | 2019-11-22 | 2020-11-20 | Adeno-associated viral vector variants |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025044678A Division JP7888221B2 (ja) | 2019-11-22 | 2025-03-19 | アデノ随伴ウイルスベクター変種 |
| JP2025116303A Division JP2025148448A (ja) | 2019-11-22 | 2025-07-10 | アデノ随伴ウイルスベクター変種 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023503455A JP2023503455A (ja) | 2023-01-30 |
| JP2023503455A5 true JP2023503455A5 (cg-RX-API-DMAC7.html) | 2024-01-30 |
| JP7712271B2 JP7712271B2 (ja) | 2025-07-23 |
Family
ID=75980202
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022529681A Active JP7712271B2 (ja) | 2019-11-22 | 2020-11-20 | アデノ随伴ウイルスベクター変種 |
| JP2025044678A Active JP7888221B2 (ja) | 2019-11-22 | 2025-03-19 | アデノ随伴ウイルスベクター変種 |
| JP2025116303A Pending JP2025148448A (ja) | 2019-11-22 | 2025-07-10 | アデノ随伴ウイルスベクター変種 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025044678A Active JP7888221B2 (ja) | 2019-11-22 | 2025-03-19 | アデノ随伴ウイルスベクター変種 |
| JP2025116303A Pending JP2025148448A (ja) | 2019-11-22 | 2025-07-10 | アデノ随伴ウイルスベクター変種 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US12653910B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4061427A4 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7712271B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102997604B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN115023242B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020388404A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022009864A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3159113A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2022008507A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL293140A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022006188A (cg-RX-API-DMAC7.html) |
| PH (1) | PH12022551247A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021102234A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL297237B2 (en) * | 2020-04-17 | 2025-08-01 | Regeneron Pharma | Detection assays for coronavirus neutralizing antibodies |
| KR20240095539A (ko) | 2021-10-08 | 2024-06-25 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 변이체 및 이의 사용 방법 |
| JP2025514794A (ja) * | 2022-04-22 | 2025-05-09 | ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア | ヒト上衣特異的プロモーターおよびその使用方法 |
| EP4522272A4 (en) * | 2022-05-11 | 2026-07-29 | Childrens Hospital Philadelphia | Adeno-associated viral vectors to target deep brain structures |
| JP2025516715A (ja) * | 2022-05-13 | 2025-05-30 | ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア | 脳微小血管系を標的とするアデノ随伴ウイルスベクター |
| CN119213120A (zh) | 2022-05-16 | 2024-12-27 | 建新公司 | 治疗异染性脑白质营养不良的方法 |
| WO2024017387A1 (en) * | 2022-07-22 | 2024-01-25 | Shanghai Vitalgen Biopharma Co., Ltd. | Novel aav capsids for targeting nervous system and uses thereof |
| KR102870168B1 (ko) * | 2022-08-26 | 2025-10-13 | 김선아 | 활막 표적화 화합물 및 이의 용도 |
| CN120187459A (zh) * | 2022-09-19 | 2025-06-20 | 费城儿童医院 | 使用split-seq在单细胞分辨率下的aav进化 |
| IL322459A (en) * | 2023-01-31 | 2025-09-01 | Childrens Hospital Philadelphia | Innovative gene therapy construct for cln2 disease |
| JP2026509271A (ja) | 2023-03-10 | 2026-03-17 | ダイノ セラピューティクス,インコーポレーテッド | カプシドポリペプチドおよびその使用方法 |
| CN117964715B (zh) * | 2023-07-21 | 2025-01-24 | 广州派真生物技术有限公司 | 腺相关病毒突变体及其应用 |
| KR20260082361A (ko) | 2023-08-31 | 2026-06-04 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 폴리펩타이드 및 이의 사용 방법 |
| WO2025090631A1 (en) * | 2023-10-23 | 2025-05-01 | The Children's Hospital Of Philadelphia | Aav vectors for delivery of apoe2 |
| CN122319003A (zh) * | 2023-10-23 | 2026-06-30 | 费城儿童医院 | 用于治疗cln2疾病的aav载体 |
| AR134407A1 (es) * | 2023-11-15 | 2026-01-14 | Genzyme Corp | Métodos de tratamiento de la enfermedad de gaucher y de la enfermedad de parkinson gba |
| CN122206466A (zh) * | 2023-11-15 | 2026-06-12 | 建新公司 | 治疗神经变性障碍的方法 |
| TW202545971A (zh) | 2024-02-08 | 2025-12-01 | 美商戴諾治療公司 | 殼體多肽及其使用方法 |
| WO2025213097A1 (en) * | 2024-04-05 | 2025-10-09 | The Children's Hospital Of Philadelphia | Novel gene therapy constructs for stxbp1 haploinsufficiency |
| WO2025231406A1 (en) * | 2024-05-02 | 2025-11-06 | The Children's Hospital Of Philadelphia | Methods to increase transduction of ependyma cells in brain |
| WO2026052039A1 (en) * | 2024-09-06 | 2026-03-12 | Sichuan Real & Best Biotech Co., Ltd. | Engineered adeno-associated virus capsid protein and the use thereof |
| WO2026064442A2 (en) | 2024-09-18 | 2026-03-26 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
| WO2026122963A1 (en) | 2024-12-06 | 2026-06-11 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
| WO2026165267A1 (en) * | 2025-01-31 | 2026-08-06 | Genzyme Corporation | Methods of treating neurodegenerative disorders |
| CN121265801A (zh) * | 2025-06-06 | 2026-01-06 | 昆明理工大学 | 一种靶向性的药物递送载体及其制备方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040031072A1 (en) * | 1999-05-06 | 2004-02-12 | La Rosa Thomas J. | Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement |
| DK2359869T3 (en) | 2001-12-17 | 2019-04-15 | Univ Pennsylvania | Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof |
| WO2006105392A2 (en) | 2005-03-30 | 2006-10-05 | The Cleveland Clinic Foundation | Neuron targeting peptides |
| CA2693712C (en) | 2007-07-14 | 2018-05-29 | The University Of Iowa Research Foundation | Methods and compositions for treating brain diseases |
| WO2011119484A1 (en) | 2010-03-23 | 2011-09-29 | Iogenetics, Llc | Bioinformatic processes for determination of peptide binding |
| US10738326B2 (en) | 2010-10-27 | 2020-08-11 | Jichi Medical University | Adeno-associated virus vector for gene transfer to nervous system cells |
| EP3564379A1 (en) | 2013-09-13 | 2019-11-06 | California Institute of Technology | Selective recovery |
| DE102014207498A1 (de) * | 2014-04-17 | 2015-10-22 | Universitätsklinikum Hamburg-Eppendorf | Viraler Vektor für den zielgerichteten Gentransfer in Gehirn und Rückenmark |
| AU2015349759B2 (en) | 2014-11-21 | 2022-01-06 | The University Of North Carolina At Chapel Hill | Aav vectors targeted to the central nervous system |
| CA2977355A1 (en) | 2015-02-20 | 2016-08-25 | University Of Iowa Research Foundation | Methods and compositions for treating genetic eye diseases |
| AU2016366549B2 (en) | 2015-12-11 | 2022-11-10 | California Institute Of Technology | Targeting peptides for directing adeno-associated viruses (AAVs) |
| CN109640949B (zh) | 2016-07-29 | 2022-11-25 | 加利福尼亚大学董事会 | 具有变异衣壳的腺相关病毒病毒体和其使用方法 |
| EP3583220A4 (en) | 2017-02-15 | 2021-07-07 | The University of North Carolina at Chapel Hill | PROCEDURES AND COMPOSITIONS FOR GENERAL TRANSFER IN THE VASCULAR SYSTEM |
| MX2019013528A (es) * | 2017-05-12 | 2020-07-14 | The Children´S Hospital Of Philadelphia | Variantes de sulfamidasa (sgsh) y vectores, composiciones, metodos y usos para tratar la mucopolisacaridosis tipo iiia (mps iiia). |
| DK3684423T5 (da) * | 2017-09-20 | 2024-08-26 | 4D Molecular Therapeutics Inc | Adeno-associerede virusvariantcapsider og fremgangsmåder til anvendelse deraf |
| MX2020003042A (es) * | 2017-09-29 | 2020-11-18 | Voyager Therapeutics Inc | Rescate del fenotipo neurológico central y periférico de la ataxia de friedreich mediante administración intravenosa. |
| WO2019113538A2 (en) | 2017-12-07 | 2019-06-13 | California Institute Of Technology | Methods and systems for noninvasive control of brain cells and related vectors and compositions |
| WO2019222329A1 (en) | 2018-05-15 | 2019-11-21 | Voyager Therapeutics, Inc. | Compositions and methods for delivery of aav |
| JP2021530218A (ja) * | 2018-07-11 | 2021-11-11 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. | 血液脳関門を超える薬剤の送達のための方法および組成物 |
| CN115605596A (zh) | 2020-02-12 | 2023-01-13 | 费城儿童医院(Us) | 用于基因表达的诱导型可变剪接调节的组合物和方法 |
-
2020
- 2020-11-20 CN CN202080094086.2A patent/CN115023242B/zh active Active
- 2020-11-20 WO PCT/US2020/061464 patent/WO2021102234A1/en not_active Ceased
- 2020-11-20 KR KR1020227021143A patent/KR102997604B1/ko active Active
- 2020-11-20 MX MX2022006188A patent/MX2022006188A/es unknown
- 2020-11-20 EP EP20890214.8A patent/EP4061427A4/en active Pending
- 2020-11-20 CN CN202510215753.2A patent/CN119978146A/zh active Pending
- 2020-11-20 BR BR112022009864A patent/BR112022009864A2/pt unknown
- 2020-11-20 US US17/778,783 patent/US12653910B2/en active Active
- 2020-11-20 CA CA3159113A patent/CA3159113A1/en active Pending
- 2020-11-20 AU AU2020388404A patent/AU2020388404A1/en active Pending
- 2020-11-20 PH PH1/2022/551247A patent/PH12022551247A1/en unknown
- 2020-11-20 JP JP2022529681A patent/JP7712271B2/ja active Active
- 2020-11-20 IL IL293140A patent/IL293140A/en unknown
-
2022
- 2022-06-16 CO CONC2022/0008507A patent/CO2022008507A2/es unknown
-
2023
- 2023-10-20 US US18/491,365 patent/US20240100194A1/en active Pending
-
2025
- 2025-03-19 JP JP2025044678A patent/JP7888221B2/ja active Active
- 2025-07-10 JP JP2025116303A patent/JP2025148448A/ja active Pending